Shares of iSpecimen Inc. (NASDAQ:ISPC – Get Free Report) were down 8.2% on Wednesday . The stock traded as low as $0.27 and last traded at $0.27. Approximately 394,523 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 2,078,512 shares. The stock had previously closed at $0.29.
iSpecimen Price Performance
The stock’s 50-day moving average is $0.32 and its 200-day moving average is $0.38.
iSpecimen (NASDAQ:ISPC – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported ($0.32) EPS for the quarter. iSpecimen had a negative return on equity of 105.25% and a negative net margin of 124.84%. The firm had revenue of $2.29 million for the quarter.
About iSpecimen
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
Featured Stories
- Five stocks we like better than iSpecimen
- What is a buyback in stocks? A comprehensive guide for investors
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- About the Markup Calculator
- Qualcomm Stock Continues to Rise in the Face of Negative News
- How to invest in marijuana stocks in 7 steps
- Top 3 Summer Stocks with Solid Growth Opportunities
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
